ArticleCureus2025
Primary Hepatic Neuroendocrine Tumor Treated With Lattice and External Beam Radiation: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuroendocrine tumors (NETs) originate from neuroendocrine cells, which receive neural input and play a key role in transmitting signals by secreting bioactive substances such as monoamines (e.g., serotonin), peptides (e.g., somatostatin), and hormones (e.g., insulin) that regulate a wide range of physiological functions. While NETs in the liver are typically metastatic, often originating from other sites in the gastrointestinal (GI) tract, they can, in rare cases, manifest as primary tumors in the liver. These are referred to as primary hepatic neuroendocrine tumors (PHNT). We present the case of a 62-year-old male patient diagnosed with PHNT confirmed through imaging and immunohistochemistry analysis. Given the rarity of this diagnosis, there are no established treatment guidelines for PHNT. In this case, lattice radiotherapy (LRT) via TomoTherapy (TomoTherapy, Inc. in Madison, WI) was selected as the first-line treatment approach for the tumor.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.